The Middle East and Africa Medical Aesthetics Market is expected to grow with a CAGR of 9.7% in the forecast period of 2023 to 2030. The years considered for the study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/jp/reports/middle-east-and-africa-medical-aesthetics-market
The Middle East and Africa medical aesthetics market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to a favorable market scenario.
The major players dealing in the Middle East and Africa medical aesthetics market are introducing a strong range of products and services and adopting strategic initiatives such as acquisition and innovation into the market. This helped companies to maximize sales with an enhanced product portfolio.
- In December 2021, Allergan (a subsidiary of AbbVie Inc.) announced that the company had completed its acquisition with Soliton, Inc. This helped company in expanding its aesthetic product portfolio in the market
Allergan (A Subsidiary of AbbVie Inc.) is the dominating player in the Middle East and Africa medical aesthetics market. Some other players in the market are Mentor Worldwide LLC (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.), Bausch Health Companies Inc., Cutera, Cynosure (A Subsidiary of Hologic, Inc.), Medytox, SharpLight Technologies Inc., Quanta System, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Candela Medical, BTL, Lumenis Be Ltd., Venus Concept, 3M, SANUWAVE and SANUWAVE Health, Inc., Dentsply Sirona, Zimmer Aesthetics, Institut Straumann AG, GALDERMA, Nobel Biocare Services AG, BioHorizons, MEGA'GEN IMPLANT CO., LTD., Sciton, and Merz North America, Inc. among others.
Allergan
Allergan is headquartered in Dublin, Ireland, and was founded in 2013. It has private ownership. The company focuses on developing, manufacturing, and commercializing branded pharmaceutical, device, surgical, and regenerative medicine products for patients worldwide. The company has several business segments such as U.S. Specialized Therapeutics, U.S.General Medicine and International, out of which U.S. Specialized Therapeutics is the market-focused segment. The company has different product categories, such as central nervous system, gastroenterology, eye care, and medical aesthetics, out of which medical aesthetics is the market-focused category.
For instance,
- In February 2022, Allergan (a subsidiary of AbbVie Inc.) announced the FDA approval of JUVÉDERM VOLBELLA XC to improve infraorbital hollows in adults above 21. This helped the company to expand its product portfolio of aesthetics in the U.S. market
The company has a wide presence across North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The subsidiaries of this company are Allergan Productos Farmaceuticos S.A., Allergan Australia Pty Limited (Australia), Inamed Pty Ltd., Collagen Vertrieb Biomedizinischer Produkte Gesellschaft m.b.H. (Germany), and Allergan N.V. among others.
Mentor Worldwide LLC
Mentor Worldwide LLC is headquartered in California, U.S., and was founded in 1969. It has private ownership. The company focuses on providing innovative products and high-quality breast implants by addressing patient needs worldwide. The company has product categories such as breast implants, breast tissue expanders, body aesthetics, tissue expanders, and others. The market-focused categories are breast implants, breast tissue expanders, body aesthetics, and tissue expanders.
For instance,
- In January 2022, Mentor Worldwide LLC (a Johnson & Johnson Medical Devices Company subsidiary) announced that the FDA had approved the MENTOR MemoryGel BOOST breast implant for breast augmentation and reconstruction. This product has helped the company to expand its product portfolio of aesthetics in the U.S. market.
The company has a presence in North America, Europe, Asia-Pacific, the Middle East and Africa. The company has subsidiaries in Mentor Texas LP (Texas), Mentor Medical Italia (Italy), S.r.l, Mentor Medical Inc, Byron Medical Inc, MDI Company Ltd, and Mentor Medical Systems (Canada) Inc among others.
Institut Straumann AG
Institut Straumann AG is headquartered in Basel, Switzerland, and was founded in 1954. It has public ownership. The company focuses on providing products and solutions in implant, restorative and regenerative dentistry. The company has several product categories, such as Dental implants, Implant-borne prosthetics, Biomaterials, and Digital Performance, from which dental implants is the market-focused category.
The company has a presence in North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
